A developer of novel anti-infective drug candidates targeting specific pathogens that cause serious infections and diseases, including C. difficile, constipation-predominant irritable bowel syndrome, Pertussis, Acinetobacter and multiple sclerosis
Focused on the precious metals, energy, life sciences and other metals sectors. Streetwise Reports features the leading investment coverage of gold, oil, uranium, biotech, pharma, rare earths, alternative energy, silver, platinum, medtech & potash.
Neurotrope (NTRP) is a biopharmaceutical and diagnostics company principally focused on developing two product platforms, a diagnostic test for Alzheimerâ€™s Disease and a drug candidate called bryostatin for the treatment of Alzheimerâ€™s Disease.
OSU Buckeye and pharmaceutical scientist. Primarily a bio/pharma swing, momentum, and position trader. I use a comprehensive approach to trading based on a sliding scale of technical and fundamental analysis that varies with every trade